ES507638A0 - Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina . - Google Patents

Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina .

Info

Publication number
ES507638A0
ES507638A0 ES507638A ES507638A ES507638A0 ES 507638 A0 ES507638 A0 ES 507638A0 ES 507638 A ES507638 A ES 507638A ES 507638 A ES507638 A ES 507638A ES 507638 A0 ES507638 A0 ES 507638A0
Authority
ES
Spain
Prior art keywords
sulfo
preparing
oxoazetidine derivatives
oxoazetidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES507638A
Other languages
English (en)
Other versions
ES8303327A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES507638A0 publication Critical patent/ES507638A0/es
Publication of ES8303327A1 publication Critical patent/ES8303327A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES507638A 1980-12-03 1981-12-02 Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina . Expired ES8303327A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1980/000293 WO1982001871A1 (en) 1980-12-03 1980-12-03 Process for preparing a 1-sulfo-2-oxoazetidine derivative

Publications (2)

Publication Number Publication Date
ES507638A0 true ES507638A0 (es) 1983-02-01
ES8303327A1 ES8303327A1 (es) 1983-02-01

Family

ID=13706129

Family Applications (1)

Application Number Title Priority Date Filing Date
ES507638A Expired ES8303327A1 (es) 1980-12-03 1981-12-02 Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina .

Country Status (5)

Country Link
EP (1) EP0053387A1 (es)
JP (1) JPS57118560A (es)
DK (1) DK534281A (es)
ES (1) ES8303327A1 (es)
WO (1) WO1982001871A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
US4224336A (en) * 1979-04-17 1980-09-23 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
DE3069587D1 (en) * 1979-06-08 1984-12-13 Takeda Chemical Industries Ltd 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP0053387A1 (en) 1982-06-09
WO1982001871A1 (en) 1982-06-10
JPS57118560A (en) 1982-07-23
DK534281A (da) 1982-06-04
ES8303327A1 (es) 1983-02-01

Similar Documents

Publication Publication Date Title
ES505373A0 (es) Un metodo para preparar derivados de fenilpiperazina
ES507332A0 (es) Un procedimiento para preparar derivados de nicotinamida.
ES499171A0 (es) Un procedimiento para preparar antibioticos de beta-lactama
ES530391A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES507065A0 (es) Un metodo para preparar derivados de 2-oxoazetidina.
ES530020A0 (es) Un metodo para preparar derivados de 3-metilflavona
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES505656A0 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
ES507975A0 (es) Un metodo para preparar derivados de pirazolina.
ES521361A0 (es) Un metodo para preparar un derivado 14-acilico de lankacidina.
ES502026A0 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES521389A0 (es) Un metodo para preparar derivados de tiazolidina.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES527705A0 (es) Un metodo para preparar derivados de fenotiazina
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
FI812065A7 (fi) Menetelmä makrolidin valmistamiseksi.
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES538032A0 (es) Un procedimiento para preparar derivados de isoxazolamina.
ES518580A0 (es) Un procedimiento para preparar un derivado de aminopropilaminobleomicina.
ES520370A0 (es) Un procedimiento para obtener derivados de isoxazolopirimidina.
FI813391A7 (fi) 2-halogeeni-3- sulfonyyliakryylinitriilien valmistusmentelmä.
FI800076A7 (fi) Menetelmä bentshydroliderivaatin valmistamiseksi.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301